Idiopathic Pulmonary Fibrosis: a Case-control Study
NCT00005295 · Status: TERMINATED · Type: OBSERVATIONAL
Last updated 2024-03-12
Summary
To determine risk factors for idiopathic pulmonary fibrosis.
Conditions
- Lung Diseases
- Pulmonary Fibrosis
- Lung Diseases, Interstitial
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of New Mexico
lead OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1989-07-31
- Completion
- 1995-06-30
More Related Trials
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
Diagnosis and Treatment of Patients With Cystic Fibrosis
NCT00001223 ·Status: TERMINATED
-
Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients
NCT05899556 ·Status: NOT_YET_RECRUITING
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
NCT00162760 ·Status: COMPLETED ·Phase: PHASE2
-
Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis
NCT04262167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis
NCT00074698 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
Gene Modifiers of Cystic Fibrosis Lung Disease
NCT00037765 ·Status: ACTIVE_NOT_RECRUITING
-
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis
NCT04397809 ·Status: COMPLETED
-
Tissue Bank for Pulmonary Diseases
NCT00546962 ·Status: UNKNOWN
-
Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
NCT00499837 ·Status: COMPLETED ·Phase: PHASE2
-
A National Registry on Chinese Patients With Cystic Fibrosis
NCT05289245 ·Status: RECRUITING
-
Statins To Treat Adult Cystic Fibrosis
NCT01092572 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations
NCT00381628 ·Status: COMPLETED
-
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver Fibrosis
NCT05229640 ·Status: WITHDRAWN ·Phase: NA
-
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364 ·Status: COMPLETED
-
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
NCT02085018 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
NCT00812045 ·Status: WITHDRAWN ·Phase: PHASE2
-
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
NCT02073409 ·Status: ENROLLING_BY_INVITATION
-
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging
NCT00023465 ·Status: UNKNOWN
-
Non-Invasive Biomarkers in Cystic Fibrosis
NCT00413140 ·Status: COMPLETED
-
Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients
NCT01806025 ·Status: COMPLETED